- Obstetrics and Gynecology
- Epidemiology
- Behavioral and Community Health
Vanessa Short, PhD, MPH
Associate Professor
Director of Research Center for MATER
Contact Information
Center for Maternal Addiction, Treatment Education, & Research
1233 Locust Street
Suite 401
Philadelphia, PA 19107
Associate Professor
Director of Research Center for MATER
Research & Clinical Interests
EDUCATION
- PhD, University of Pittsburgh, Epidemiology (2009)
- MPH, University of Pittsburgh, Behavioral and Community Health (2005)
Most Recent Peer-Reviewed Publications
- Can riboflavin offer a novel personalised strategy for maintaining healthy blood pressure in pregnancy in populations globally?
- Understanding How Persons With Maternal Opioid Use Disorder Experience Public Food Assistance Programs WIC and SNAP
- Breastfeeding Continuation at One Month Postpartum Among Women in Treatment for Opioid Use Disorder Who Initiated Breastfeeding: Prevalence and Determinants
- A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration
- “Someone is there with you through this [pregnancy] that isn't seeing you through a negative lens”: Considerations for integrating doula referrals into opioid treatment programs
Professional Memberships
- Consortium of Universities for Global Health
- Pediatric Academic Society
- Academy Health
- American Public Health Association
- Society of Behavioral Medicine
FUNDING
- 2026-2028, MPI. Group based well child care for mothers with history of hypertensive disorder during pregnancy. NICHD/NIH
- 2026-2028, Co-I. Xylazine, Pregnancy, and Access to Care. NIDA/NIH
- 2024 - 2029, MPI. Breastfeeding Education Support Tool for Baby. NICHD, 1R01HD112492
- 2024-2030, PI. Addressing the needs of pregnant women with opioid use disorder with group prenatal care (Phase I & II). NIH IMPROVE-Community Implementation Program (CIP)
- 2024-2026, Co-I. Developing Telemedicine Services to Support Patients Eligible to Receive MOUD Treatment. Independence Blue Cross Clinical Care Innovation Program
- 2024-2026, Co-I. Preparing Opioid Treatment Programs and Providers for Effective Methadone Management Among Pregnant People. Elevance Health Foundation
- 2022–2024, Co-I. Doula Support Engagement in a Population of Pregnant and Parenting Women in Drug Treatment, U.S. DHHS, AHRQ, 1R03HS028498
- 2020–2025, PI. Group well child care intervention for infants of mothers in treatment for opioid use disorder, U.S. DHHS, AHRQ, 1R18HS027399-01
- 2020–2023, Co-I. Reducing Anemia in Pregnancy in India: the RAPIDIRON Trail, Children’s Investment Fund Foundation (United Kingdom)
- 2020–2023, Co-I. RAPIDIRON-KIDS Study, Children’s Investment Fund Foundation (United Kingdom)
- 2018–2023, Co-I. Supporting Women and Children in Substance Abuse Recovery - A Family Unit Approach, U.S. DHHS, SAMHSA, H79TI080335
- 2021-2022, PI. Primary care perceptions and needs of women in treatment for opioid use disorder, Thomas Jefferson University Faculty Seed Award
- 2020–2022, Co-I. Pregnancy Support Services, Pennsylvania Department of Drug and Alcohol Programs
- 2021, Co-I, Primary Stakeholder Evaluation of Acute Care Induction Period for Women Entering Substance Use Treatment, Thomas Jefferson University College of Nursing Stratton Foundation Scholar Award
- 2021, Co-I. Pediatrician Knowledge, Attitudes, and Practices for Well Child Care for Children Affected By Maternal Opioid Use Disorder, Nemours Research Pilot Award
Selected AWARDS & HONORS
- 2024, Provost Award for Clinical/Translational Research, Thomas Jefferson University
- 2023, 3rd Place Oral Presentation: "Group prenatal care for pregnant women with opioid use disorder: preliminary evidence for benefits compared to individual prenatal care", Sidney Kimmel Medical College Research Symposium, Thomas Jefferson University
- 2021, Faculty Seed Award, Thomas Jefferson University
- 2021, Stratton Foundation Scholar Award, Thomas Jefferson University